Document Detail


Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression.
MedLine Citation:
PMID:  23001907     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The human epididymis 4 (HE4) protein is expressed in the epididymis and respiratory tract. We previously reported that HE4 is also expressed in pulmonary adenocarcinoma. The purpose of this study was to investigate serum levels of HE4 as a biological marker in pulmonary adenocarcinoma. As the trained set, 102 patients with pulmonary adenocarcinoma who underwent surgery in our institute from 2008 to 2011 were evaluated. They were compared with 58 healthy controls and 16 cases of benign lung disease. In the validation, we used 104 patients with pulmonary adenocarcinoma operated on between 2000 and 2007. Postoperative changes of serum HE4 levels were investigated in 35 patients. The level of HE4 was determined by enzyme immunometric assay and compared with clinicopathological factors. In the trained set, HE4 levels in sera in pulmonary adenocarcinoma were significantly higher than in healthy controls and benign lung disease. Receiver operating characteristic curve showed that HE4 was a good discriminator of pulmonary adenocarcinoma (cut-off point, 50.3 pM; area under curve, 0.825; 95 % confidence interval, 0.76-0.89, p < 0.001). In the validation set, serum HE4 levels were significantly correlated with age, nodal status, and carcinoembryonic antigen. Furthermore, postoperative increase of HE4 serum levels showed a significant correlation with recurrence (p = 0.032). The 5-year overall survival rate was 52.6 % in the HE4-positive group compared with 97.1 % in the HE4-negative group (p = 0.001). These data showed that HE4 expression in sera is associated with progression of pulmonary adenocarcinoma and a possible biomarker.
Authors:
Shin-Ichi Yamashita; Keita Tokuishi; Toshihiko Moroga; Satoshi Yamamoto; Kazuyuki Ohbo; So Miyahara; Yasuhiro Yoshida; Jun Yanagisawa; Daisuke Hamatake; Masafumi Hiratsuka; Yasuteru Yoshinaga; Takeshi Shiraishi; Akinori Iwasaki; Katsunobu Kawahara
Related Documents :
22958767 - Wire-probing technique to revascularize subacute or chronic internal carotid artery occ...
25130127 - A rare case of diffuse pulmonary nodules in a patient with adult-onset still's disease.
25061737 - Clinical effects and safety review of self-expanding stent surgery for extracranial car...
24062897 - Outcomes of percutaneous femoral cannulation for venoarterial extracorporeal membrane o...
22958767 - Wire-probing technique to revascularize subacute or chronic internal carotid artery occ...
23538407 - Histopathologic evaluation of arterial wall response to 5 neurovascular mechanical thro...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-22
Journal Detail:
Title:  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine     Volume:  -     ISSN:  1423-0380     ISO Abbreviation:  Tumour Biol.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8409922     Medline TA:  Tumour Biol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of General Thoracic, Breast and Pediatric Surgery, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonanku, Fukuoka, 814-0180, Japan, yamashi1@med.oita-u.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Survey of the camel urinary proteome by shotgun proteomics using a multiple database search strategy...
Next Document:  Heterozygosity for TGF ?1 -509C/T Polymorphism is associated with risk for breast cancer in South In...